“Türkiye's First Manned Space Mission” discussed at Rare Diseases Congress

Asst. Prof. Cihan Taştan, Director of Üsküdar University Transgenic Cell Technologies and Epigenetic Research Center (TRGENMER), and Beyza Aydın, TRGENMER R&D Officer, attended the “Rare Diseases Congress” hosted by Biruni University. At the congress, where awareness and current scientific approaches to rare diseases were discussed, topics such as genetically based diseases, diagnostic processes, personalized medicine practices, and patient experience were comprehensively evaluated.

Attending the congress held at Biruni University Conference Hall, Asst. Prof. Cihan Taştan, Director of TRGENMER, shared his presentation titled “The Effect of Microgravity on Astronauts within the Scope of Türkiye's First Manned Space Mission: Discovered Genes, Longevity, and Immunity” with the participants. 

The contributions of space biology studies to human health were discussed

The presentation discussed the potential contributions of space biology studies to understanding human health and disease mechanisms. It was emphasized that examining genetic and biological changes occurring under microgravity conditions offers new perspectives in understanding the immune system, aging mechanisms, and the biology of various diseases. 

An important opportunity for the development of new treatment strategies

Dr. Taştan stated that biological research conducted in space holds significant scientific potential not only for space medicine but also for understanding the mechanisms of rare and genetic diseases and developing new treatment strategies in the future. 

Information about TRGENMER’s research was provided

Within the scope of the congress, Asst. Prof. Cihan Taştan and TRGENMER R&D Officer Beyza Aydın, who also met with Biruni University students, provided information about gene therapies, rare diseases, and advanced biotechnology research conducted at Üsküdar University TRGENMER Center. 

During the congress, students' questions were also answered, and evaluations were made for young researchers about scientific studies and career opportunities in the field of translational biotechnology. 

Attending the congress held at Biruni University Conference Hall, Asst. Prof. Cihan Taştan, Director of TRGENMER, shared his presentation titled “The Effect of Microgravity on Astronauts within the Scope of Türkiye's First Manned Space Mission: Discovered Genes, Longevity, and Immunity” with the participants. 

The contributions of space biology studies to human health were discussed

The presentation discussed the potential contributions of space biology studies to understanding human health and disease mechanisms. It was emphasized that examining genetic and biological changes occurring under microgravity conditions offers new perspectives in understanding the immune system, aging mechanisms, and the biology of various diseases. 

An important opportunity for the development of new treatment strategies

Dr. Taştan stated that biological research conducted in space holds significant scientific potential not only for space medicine but also for understanding the mechanisms of rare and genetic diseases and developing new treatment strategies in the future. 

Information about TRGENMER’s research was provided

Within the scope of the congress, Asst. Prof. Cihan Taştan and TRGENMER R&D Officer Beyza Aydın, who also met with Biruni University students, provided information about gene therapies, rare diseases, and advanced biotechnology research conducted at Üsküdar University TRGENMER Center. 

During the congress, students' questions were also answered, and evaluations were made for young researchers about scientific studies and career opportunities in the field of translational biotechnology.